Janus Henderson Group
AZN icon

Janus Henderson Group’s AstraZeneca AZN Stock Holding History

Janus Henderson Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.32B Buy
11,949,424
+11,345,846
+1,880% +$2.19B 1.11% 10
2025
Q4 		$111M Sell
603,578
-46,365
-7% -$8.13M 0.05% 267
2025
Q3 		$99.7M Sell
649,943
-615,962
-49% -$93.2M 0.05% 278
2025
Q2 		$177M Buy
1,265,905
+182,284
+17% +$25.5M 0.09% 197
2025
Q1 		$160M Buy
1,083,621
+61,491
+6% +$8.9M 0.09% 204
2024
Q4 		$134M Buy
1,022,130
+187,353
+22% +$26.2M 0.07% 245
2024
Q3 		$130M Buy
834,777
+42,751
+5% +$6.9M 0.07% 242
2024
Q2 		$124M Sell
792,026
-74,077
-9% -$11.1M 0.07% 238
2024
Q1 		$117M Buy
866,103
+1,475
+0.2% +$195K 0.06% 240
2023
Q4 		$116M Sell
864,628
-57,429
-6% -$7.47M 0.07% 238
2023
Q3 		$125M Sell
922,057
-220,859
-19% -$30.2M 0.08% 218
2023
Q2 		$164M Sell
1,142,916
-194,792
-15% -$28.7M 0.1% 191
2023
Q1 		$186M Sell
1,337,708
-188,138
-12% -$25.3M 0.12% 171
2022
Q4 		$207M Sell
1,525,846
-1,870,092
-55% -$235M 0.15% 154
2022
Q3 		$372M Buy
3,395,938
+1,594,973
+89% +$202M 0.14% 166
2022
Q2 		$238M Sell
1,800,965
-266,373
-13% -$35M 0.16% 151
2022
Q1 		$274M Sell
2,067,338
-1,252,200
-38% -$150M 0.13% 171
2021
Q4 		$387M Sell
3,319,538
-110,595
-3% -$13M 0.16% 146
2021
Q3 		$412M Buy
3,430,133
+124,816
+4% +$14.5M 0.18% 128
2021
Q2 		$396M Buy
3,305,317
+1,347,669
+69% +$148M 0.17% 140
2021
Q1 		$195M Buy
1,957,648
+1,537,042
+365% +$155M 0.09% 224
2020
Q4 		$42.1M Buy
420,606
+117,527
+39% +$12.4M 0.02% 584
2020
Q3 		$33.2M Buy
303,079
+25,522
+9% +$2.84M 0.02% 601
2020
Q2 		$29.4M Sell
277,557
-13,019
-4% -$1.34M 0.02% 619
2020
Q1 		$26M Sell
290,576
-8,851
-3% -$833K 0.02% 610
2019
Q4 		$29.9M Sell
299,427
-33,306
-10% -$3.14M 0.02% 729
2019
Q3 		$29.7M Sell
332,733
-10,030
-3% -$870K 0.02% 733
2019
Q2 		$28.3M Buy
342,763
+2,376
+0.7% +$186K 0.02% 721
2019
Q1 		$27.5M Buy
340,387
+22,471
+7% +$1.77M 0.02% 714
2018
Q4 		$24.1M Sell
317,916
-52,939
-14% -$4.13M 0.02% 704
2018
Q3 		$29.4M Buy
370,855
+8,282
+2% +$626K 0.02% 718
2018
Q2 		$25.5M Sell
362,573
-2,235
-0.6% -$161K 0.01% 742
2018
Q1 		$25.5M Buy
364,808
+5,639
+2% +$391K 0.02% 736
2017
Q4 		$24.9M Sell
359,169
-4,131
-1% -$279K 0.02% 704
2017
Q3 		$24.6M Buy
363,300
+357,094
+5,754% +$22.6M 0.02% 690
2017
Q2 		$423K Sell
6,206
-9,483
-60% -$619K ﹤0.01% 1247
2017
Q1 		$977K Hold
15,689
– – 0.01% 686
2016
Q4 		$857K Hold
15,689
– – 0.01% 712
2016
Q3 		$1.03M Hold
15,689
– – 0.01% 644
2016
Q2 		$947K Hold
15,689
– – 0.01% 649
2016
Q1 		$884K Buy
+15,689
New +$943K 0.01% 675
2015
Q3 		– Sell
-15,760
Closed -$1M – 834
2015
Q2 		$1M Buy
15,760
+6,160
+64% +$422K 0.01% 681
2015
Q1 		$657K Hold
9,600
– – 0.01% 748
2014
Q4 		$676K Hold
9,600
– – ﹤0.01% 742
2014
Q3 		$686K Buy
+9,600
New +$703K 0.01% 671

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Janus Henderson Group's AZN Position: Q1 2026 in Review

Janus Henderson Group increased its AstraZeneca (AZN) stake by 1,880% in Q1 2026, buying an estimated $2.19B and bringing the position to 11,949,424 shares worth $2.32B. The position accounts for 1.11% of the portfolio, ranked #10.

Janus Henderson Group first reported a position in AZN in Q3 2014 and has held it in 45 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Janus Henderson Group held 11,949,424 shares of AstraZeneca worth $2.32B as of Q1 2026.
  • Janus Henderson Group bought 11,345,846 AstraZeneca shares in Q1 2026, an estimated $2.19B.
  • AstraZeneca made up 1.11% of Janus Henderson Group's portfolio in Q1 2026, its #10 holding.
  • Janus Henderson Group first reported a position in AstraZeneca in Q3 2014 and has held it in 45 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.